Scientists from the University of Liverpool and their global collaborators have highlighted the most effective treatments for ...

Atalanta Therapeutics, a biotechnology company pioneering RNA interference (RNAi) for the treatment of neurological diseases, today announced the completion of a $97 million Series B financing to ...

Nigerians are projected to experience three times the current burden of brain disorders by 2030, Temitope Farombi a ...

Researchers at the Institute of Environmental Medicine, Karolinska Institutet have taken an important step toward ...

The number of people living with neurological disorders, such as Alzheimer’s disease, epilepsy, multiple sclerosis and ...

The company, co-founded by Nobel Laureate Craig Mello, aims to push molecules for Huntington’s and a form of epilepsy into Phase I trials, with additional preclinical assets targeting Parkinson’s and ...

Explore the role of preclinical MRI in studying neurological diseases, with a focus on advanced cellular and molecular ...

Ncardia, a global leader in human induced pluripotent stem cell (hiPSC) technology, today announced the launch of Ncyte® ...

Research explores the profound impact of climate change on neurological health, focusing on how rising temperatures, extreme ...

One fateful morning, 75-year-old Ambika Devi suddenly felt the room around her spinning, reminiscent of an amusement park ...

Compared with adults aged 65 and older, those aged 18 to 64 are more affected by long COVID neurologic symptoms.

The Clinic's study has already enrolled 3,600 participants, but the goal is a diverse group of 200,000. Right now, more men ...